Redmile Group, LLC Celldex Therapeutics, Inc. Transaction History

Redmile Group, LLC

$1.28 Billion
Q4 2024

A detailed history of Redmile Group, LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Redmile Group, LLC holds 615,775 shares of CLDX stock, worth $12.7 Million. This represents 1.22% of its overall portfolio holdings.

Number of Shares

615,775

Previous 657,175 6.3%

Holding current value

$12.7 Million

Previous $22.3 Million 30.3%

% of portfolio

1.22%

Previous 1.46%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$23.31 - $32.4 $965,034 - $1.34 Million	-41,400 Reduced 6.3%	615,775 $15.6 Million
Q3 2024 Nov 14, 2024	SELL	$32.06 - $44.56 $1.97 Million - $2.74 Million	-61,548 Reduced 8.56%	657,175 $22.3 Million
Q2 2024 Aug 14, 2024	SELL	$32.76 - $42.56 $5.82 Million - $7.56 Million	-177,731 Reduced 19.83%	718,723 $26.6 Million
Q1 2024 May 15, 2024	SELL	$35.22 - $51.88 $3.43 Million - $5.05 Million	-97,349 Reduced 9.8%	896,454 $37.6 Million
Q4 2023 Feb 14, 2024	SELL	$22.61 - $40.65 $15.9 Million - $28.5 Million	-702,201 Reduced 41.4%	993,803 $39.4 Million
Q2 2023 Aug 14, 2023	SELL	$30.29 - $38.28 $5.57 Million - $7.03 Million	-183,735 Reduced 9.77%	1,696,004 $57.5 Million
Q1 2023 May 15, 2023	SELL	$34.78 - $47.43 $3.4 Million - $4.63 Million	-97,712 Reduced 4.94%	1,879,739 $67.6 Million
Q4 2022 Feb 14, 2023	SELL	$27.78 - $45.38 $213,906 - $349,426	-7,700 Reduced 0.39%	1,977,451 $88.1 Million
Q3 2022 Nov 14, 2022	SELL	$22.7 - $37.57 $1.93 Million - $3.2 Million	-85,137 Reduced 4.11%	1,985,151 $55.8 Million
Q2 2022 Aug 15, 2022	BUY	$20.5 - $37.33 $492,389 - $896,629	24,019 Added 1.17%	2,070,288 $55.8 Million
Q1 2022 May 16, 2022	SELL	$27.64 - $39.32 $3.3 Million - $4.69 Million	-119,317 Reduced 5.51%	2,046,269 $69.7 Million
Q4 2021 Feb 14, 2022	SELL	$35.68 - $56.27 $31.3 Million - $49.4 Million	-877,712 Reduced 28.84%	2,165,586 $83.7 Million
Q3 2021 Nov 15, 2021	BUY	$28.95 - $55.99 $903,732 - $1.75 Million	31,217 Added 1.04%	3,043,298 $164 Million
Q2 2021 Aug 16, 2021	SELL	$20.71 - $35.37 $7.78 Million - $13.3 Million	-375,707 Reduced 11.09%	3,012,081 $101 Million
Q1 2021 May 17, 2021	BUY	$16.19 - $29.91 $10.9 Million - $20.2 Million	676,172 Added 24.94%	3,387,788 $69.8 Million
Q4 2020 Feb 16, 2021	BUY	$14.99 - $22.75 $10.8 Million - $16.4 Million	722,416 Added 36.32%	2,711,616 $47.5 Million
Q3 2020 Nov 16, 2020	SELL	$9.65 - $15.19 $104,220 - $164,052	-10,800 Reduced 0.54%	1,989,200 $29.5 Million
Q2 2020 Aug 14, 2020	BUY	$1.61 - $13.41 $3.22 Million - $26.8 Million	2,000,000 New	2,000,000 $26 Million

Others Institutions Holding CLDX

# of Institutions

197

Shares Held

69.7M

Call Options Held

960K

Put Options Held

675K

View Full List

About Celldex Therapeutics, Inc.

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $967M
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

More about CLDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmile Group, LLC with notifications on news.

Account

Redmile Group, LLC Celldex Therapeutics, Inc. Transaction History